Expectations for Artificial Intelligence (AI) in Psychiatry.
Journal article
Monteith S. et al, (2022), Curr Psychiatry Rep
A co-produced online cultural experience compared to a typical museum website for mental health in people aged 16-24: A proof-of-principle randomised controlled trial.
Journal article
Syed Sheriff RJ. et al, (2022), Aust N Z J Psychiatry
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Journal article
Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754
Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic Review.
Journal article
Zangani C. et al, (2022), JMIR Ment Health, 9
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Journal article
PHOSP-COVID Collaborative Group None., (2022), Lancet Respir Med, 10, 761 - 775
Psychosocial markers of age at onset in bipolar disorder: a machine learning approach.
Journal article
Bolton S. et al, (2022), BJPsych Open, 8
Using a generative model of affect to characterize affective variability and its response to treatment in bipolar disorder.
Journal article
Pulcu E. et al, (2022), Proc Natl Acad Sci U S A, 119
Associating Violence With Schizophrenia-Risks and Biases-Reply.
Journal article
Whiting D. et al, (2022), JAMA Psychiatry, 79, 739 - 740
Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis.
Journal article
Mitter P. et al, (2022), Sleep Med Rev, 64
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
Journal article
Freeman D. et al, (2022), Lancet Psychiatry, 9, 375 - 388
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.
Journal article
Au-Yeung SK. et al, (2022), Evid Based Ment Health, 25, 77 - 83
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment.
Journal article
McKeown L. et al, (2022), J Psychopharmacol
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19.
Journal article
Houchen-Wolloff L. et al, (2022), Thorax
Association between serum lithium level and incidence of COVID-19 infection.
Journal article
De Picker LJ. et al, (2022), Br J Psychiatry, 1 - 3
Mental health prior to and during the COVID-19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data.
Journal article
Lewis KJS. et al, (2022), Bipolar Disord
Commercial Use of Emotion Artificial Intelligence (AI): Implications for Psychiatry.
Journal article
Monteith S. et al, (2022), Curr Psychiatry Rep, 24, 203 - 211
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale.
Journal article
Hong JSW. et al, (2022), Mol Psychiatry, 27, 1339 - 1349
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries: A Systematic Review and Meta-analysis.
Journal article
Whiting D. et al, (2022), JAMA Psychiatry, 79, 120 - 132
Pharmacological treatment for psychotic depression.
Journal article
Kruizinga J. et al, (2021), Cochrane Database Syst Rev, 12